Below is an excerpt from a letter written on June 25, 2009 and sent by the IDSA to US Representative Henry Waxman, Chairman of the House Energy & Commerce Committee. In it, the IDSA makes clear that it opposes the bill regarding the bill concerning Lyme disease treatment (H.R. 1179), which was recently reintroduced in the House of Representatives.